Avalon Globocare Corp
NASDAQ:ALBT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Avalon Globocare Corp
Accounts Payable
Avalon Globocare Corp
Accounts Payable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Avalon Globocare Corp
NASDAQ:ALBT
|
Accounts Payable
$253.8k
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Accounts Payable
$1.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
|
CVS Health Corp
NYSE:CVS
|
Accounts Payable
$59.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
15%
|
|
|
Cigna Corp
NYSE:CI
|
Accounts Payable
$10.7B
|
CAGR 3-Years
11%
|
CAGR 5-Years
14%
|
CAGR 10-Years
5%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Accounts Payable
$840.8m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Accounts Payable
$54.4m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
Avalon Globocare Corp
Glance View
Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and the provision of healthcare services. The company is headquartered in Freehold, New Jersey and currently employs 5 full-time employees. The company went IPO on 2016-02-22. The firm is focused on the fields of cellular immunotherapy, including CAR-T/NK; exosome technology (ACTEX), and COVID-19-related vaccine and therapeutics through its subsidiaries. The company operates through two business segments: real property operating segment and medical related consulting services segment. The firm also provides strategic advisory and outsourcing services to facilitate and improve its clients’ growth and development, as well as competitiveness in healthcare and CellTech industry markets. Its downstream medical team and facility consists of affiliated hospital networks and experts specialized in hematology, oncology, cellular immunotherapy, hematopoietic stem/progenitor cell transplant, as well as regenerative therapeutics. Its clinical programs include AVA-001, ACTEX, FLASH-CAR, and AVA-Trap.
See Also
What is Avalon Globocare Corp's Accounts Payable?
Accounts Payable
253.8k
USD
Based on the financial report for Sep 30, 2025, Avalon Globocare Corp's Accounts Payable amounts to 253.8k USD.
What is Avalon Globocare Corp's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
-25%
Over the last year, the Accounts Payable growth was -71%. The average annual Accounts Payable growth rates for Avalon Globocare Corp have been -41% over the past three years , -25% over the past five years .
